DNA · Healthcare · $838M
$12.83+7.27%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출은 2,000만 달러로 전년 동기 대비 48% 급감했고, 직전 분기($19M)보다도 낮은 수준의 정체가 이어졌어요.”
In the company's words · 2026 2분기 earnings call